Abstract: Advanced critical real-time embedded systems (CRTES) like autonomous cars impose dependability and highperformance requirements. Parallel architectures are increasingly adopted to cope with ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results